In a recent webinar, Dr. Amber Van Laar, a movement disorder specialist and neurologist, provided a deep dive into the evolving landscape of stem cell and gene therapies for Parkinson’s disease.
As the Senior Vice President of Global Clinical Development at AskBio, Dr. Van Laar discussed innovative cell-based therapies and the potential for gene therapy to alter the progression of Parkinson’s, targeting the underlying causes rather than just symptoms.
The session explored the challenges, progress, and clinical trials in regenerative medicine, highlighting how stem cell therapy could one day replace damaged brain cells and reverse neurodegeneration.
This exciting discussion sheds light on how cutting-edge stem cell research offers hope to those battling Parkinson’s, with the promise of groundbreaking treatments on the horizon.
Watch the full webinar here: